N.E.W. Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
976
+71
+8% +$72.5K 0.08% 93
2026
Q1
$832K Buy
905
+242
+37% +$245K 0.06% 108
2025
Q4
$713K Hold
663
0.05% 117
2025
Q3
$506K Buy
663
+1
+0.2% +$744 0.05% 116
2025
Q2
$516K Sell
662
-398
-38% -$309K 0.05% 112
2025
Q1
$876K Buy
1,060
+345
+48% +$287K 0.07% 89
2024
Q4
$551K Sell
715
-7
-1% -$5.8K 0.05% 108
2024
Q3
$640K Hold
722
0.06% 96
2024
Q2
$654K Buy
722
+40
+6% +$32K 0.07% 90
2024
Q1
$531K Sell
682
-5
-0.7% -$3.56K 0.06% 98
2023
Q4
$401K Buy
687
+11
+2% +$6.42K 0.05% 115
2023
Q3
$363K Buy
676
+100
+17% +$51.5K 0.05% 112
2023
Q2
$270K Buy
+576
New +$242K 0.04% 114

Other funds holding LLY

N.E.W. Advisory Services's LLY Position: Q2 2026 in Review

N.E.W. Advisory Services increased its Eli Lilly (LLY) stake by 7.8% in Q2 2026, buying an estimated $72.5K and bringing the position to 976 shares worth $1.17M. The position accounts for 0.08% of the portfolio, ranked #93.

N.E.W. Advisory Services first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 2,861 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • N.E.W. Advisory Services held 976 shares of Eli Lilly worth $1.17M as of Q2 2026.
  • N.E.W. Advisory Services bought 71 Eli Lilly shares in Q2 2026, an estimated $72.5K.
  • Eli Lilly made up 0.08% of N.E.W. Advisory Services's portfolio in Q2 2026, its #93 holding.
  • N.E.W. Advisory Services first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 2,861 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.